-
IRVING, Texas and NEW YORK, Nov. 20, 2017 — Avista Capital Partners (“Avista”), a leading private equity firm, today announced the completion of its acquisition of Inform Diagnostics Life Sciences (“MLS” or the “Company”) from Miraca Holdings Inc. Continue reading the press release at the Avista website.
Continue Reading
-
IRVING, Texas, October 16, 2017 — Inform Diagnostics Life Sciences, the largest U.S. independent anatomic pathology laboratory, continues to expand in clinical pathology: its InformTx™ therapeutic drug monitoring (TDM) has begun the validation process for Renflexis™ (infliximab-abda), a biosimilar of Remicade® (infliximab). Testing will be commercially available in early ...
Continue Reading
-
Posted By
Jody Cain / Colleen Murphy
MLS to market Biocept’s proprietary liquid biopsy testing platform in key sales territories, with potential to expand the agreement in the future SAN DIEGO (October 3, 2017) – Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that ...
Continue Reading
-
IRVING, TX, NEW YORK, NY, and TOKYO, September 22, 2017 – Avista Capital Partners (“Avista”), a leading private equity firm, and Miraca Holdings Inc. (“MHD”) announced today that Avista has signed a definitive agreement to acquire Miraca Life Sciences (“MLS” or “the Company”), a wholly-owned subsidiary of Miraca Holdings Inc. Continue reading ...
Continue Reading
-
Pathologists at Inform Diagnostics contributed significantly in the development of a new product from Philips, the IntelliSite Pathology Solution. As one of four clinical study sites, Inform Diagnostics participated in “one of the largest studies ever conducted to directly compare the use of digital pathology to optical microscopes.” At Inform Diagnostics, participation in the Philips ...
Continue Reading
-
IRVING, Texas, April 12, 2017 — Ten research projects from the GI pathologists at Inform Diagnostics, the nation’s largest independent anatomic pathology lab, have been accepted for presentation at the Digestive Disease Week® conference (DDW), which will be held May 6–9 in Chicago. DDW is the world’s largest gathering of physicians, researchers and industry in the ...
Continue Reading
-
IRVING, Texas, March 28, 2017 — Inform Diagnostics, the largest U.S. independent anatomic pathology laboratory, continues to expand its InformTx™ therapeutic drug monitoring (TDM) capabilities, now testing for Simponi (golimumab) as well as patient-developed antibodies to Simponi. This is the first TDM assay available in the United States for Simponi. With this addition, Inform ...
Continue Reading